Cell fusion is a powerful tool for understanding the molecular mechanisms of epigenetic reprogramming. In hybrid cells of somatic cells and pluripotential stem cells, including embryonic stem (ES) and embryonic germ cells, somatic nuclei acquire pluripotential competence. ES and embryonic germ cells retain intrinsic trans activity to induce epigenetic reprogramming. For generating hybrid cells, we have used the technique of electrofusion. Electrofusion is a highly effective, reproducible, and biomedically safe in vitro system. For successful cell fusion, two sequential steps of electric pulse stimulation are required for the alignment (pearl chain formation) of two different types of cells between electrodes in response to alternating current stimulation and for the fusion of cytoplasmic membranes by direct current stimulation. Optimal conditions for electrofusion with a pulse generator are introduced for ES and somatic cell fusion. Topics in the field of stem cell research include the successful production of cloned animals via the epigenetic reprogramming of somatic cells and contribution of spontaneous cell fusion to generating intrinsic plasticity of tissue stem cells. Cell fusion technology may make important contributions to the fields of epigenetic reprogramming and regenerative medicine.
Introduction
Cell fusion is a phenomenon combining genetic and epigenetic information between two different types of cells, resulting in the creation of a new cellular phenotype and function. Fused cells can grow as polynuclear cells, called heterokaryons. In other cases, one combined nucleus is formed through cell division after cytoplasmic membrane fusion. The phenotype of hybrid cells varies depending on the combination of parental cells for fusion. Specialized gene products from one of the parental cells are maintained; others are often extinguished via a tissue-specific repressive mechanism, a phenomenon called extinction (1). Thus, it has been believed that epigenetic information derived from parental cells coordinately regulates the new phenotypes and functions of somatic hybrid cells.
One well-known cell fusion phenomenon occurring in vivo is fertilization. The union of two pronuclei from an MII oocyte and sperm creates the next generation with genetic diversity. Soon after fertilization, sperm chromatin is reprogrammed by nucleoplasmin because of the exchange of sperm-specific basic proteins to histones (2), almost resulting in the equalization of paternal and maternal chromatin through subsequent cell divisions. Cell fusion is also involved in the technique of animal cloning. The somatic donor nucleus is introduced into a recipient MII oocyte by cell fusion or direct injection. In the cloned embryos, the somatic type of cell phenotype and function is reprogrammed to the pluripotential type as a result of genomewide epigenetic modifications via the activity of trans-acting factors preserved in unfertilized oocytes. This phenomenon has been called nuclear reprogramming.
Using electrofusion between ES cells and adult somatic cells, it has been demonstrated that ES cells have an intrinsic capacity for the nuclear reprogramming of specialized somatic genomes (3, 4) . In hybrid cells of ES cells and thymocytes, epigenetic modifications specific to somatic cells are fully reprogrammed to the ES epigenotype, as shown by (1) the successful contribution of the ES hybrid cells to the normal embryogenesis of chimeric embryos, (2) reactivation of the inactivated X chromosome derived from female thymocytes, (3) reactivation of pluripotential cellspecific genes (Oct4 and Tsix) derived from somatic cells, (4) tissue-specific gene expression from the reprogrammed somatic genomes after in vivo and in vitro differentiation, and (5) de-condensed chromatin formation in the reprogrammed somatic nuclei as marked by histone-tail modifications of H3 and H4 hyperacetylation and H3 lysine 4 hypermethylation (3,5,6). Moreover, embryonic germ (EG) cells derived from gonadal primordial germ cells of mouse E11.5 and 12.5 embryos, in which the majority of parental imprints are erased (7), possess additional activity for inducing reprogramming of parental imprints on somatic genomes accompanied by DNA demethylation in the EG hybrid cells (8). Therefore, electrofusion between pluripotential stem cells and somatic cells will contribute to our understanding of the mechanisms of nuclear reprogramming involved in epigenetic modifications on DNA and chromatin.
Cell fusion was first induced by the Sendai virus (HVJ) among Ehrlich's ascites tumor cells, resulting in the formation of giant polynuclear cells (9). Since Harris's group reported cell fusion between two different species, mouse and human, in 1965 (10), the technique has proven to be a powerful approach to analyzing biological interactions between differentiated cell types. Various techniques lead to cell fusion mediated by other viruses such as Paramyxoviruses, including Oncornavirus, Coronavirus, Herpesvirus, and Poxvirus and by treatment with various chemical agents such as calcium ions, lysolecithin, and polyethylene glycol (PEG). However, virus-and chemicalmediated cell fusion has difficulties with respect to the efficiency of inducing cell fusion and reproducibility and biomedical safety for clinical applications. Since the 1980s, efforts have been made to optimize many parameters of electrofusion, resulting in improvements in fusion efficiency, which is now significantly better than that of cell fusion with polyethylene glycol (11). The electrofusion parameters, however, were optimized for making hybridomas for the stable production of antibodies.
In this chapter, we introduce an electrofusion procedure to create hybrid cells from pluripotential stem cells and adult lymphocytes. The overall procedure is summarized (see Fig. 1 ). The electrofusion procedure is subdivided into several parts: (1) cell culture of ES and fused cells; (2) pretreatment of somatic cells; (3) setup of the Electro Cell Manipulator (ECM) 2001 (BTX), AC (alternating current)/DC (direct current) pulse generator with a Microslide chamber; (4) operation of the electrofusion generator; (5) selection of postfusion cells; and (6) isolation and cloning of fused cells. In the process of electrofusion, AC pulses induce the alignment and compression of the cells, and DC pulses transiently make revertible pores in cytoplasmic membranes to initiate the process of fusion among cells. The alignment voltage, pulse length, and electroporation voltage and the number of DC pulses should be precisely controlled.
After cell fusion, ES hybrid cells with somatic cells should be isolated with selection medium. Thus, genetically marked ES cells or somatic cells are needed for cell fusion experiments. For example, normal ES cells were hybridized with thymocytes derived from ROSA26 transgenic mice, which carry the ubiquitously expressed neo/lacZ transgene (12). Consequently, ES cells hybridized with the thymocytes can survive and grow only in medium supplemented with a protein synthesis inhibitor, G418. The ES hybrid cells and their derivatives are visualized as cells positive for X-gal (5-bromo-4-chloro-3-indolyl-β-D-galactoside) staining, which allows one to observe their contribution in chimeric embryos and tissues (3,5,8).
In another selection system, male ES cells deficient in the Hprt gene on the X chromosome are used for isolating ES hybrid cells with wild-type somatic cells. The somatic cell-derived Hprt gene rescues the HPRT activity in the hybrid cells. In DNA synthesis, the purine nucleotide can be synthesized by the de novo pathway and recycled by the salvage pathway. When electrofusion-treated cells are cultured in medium with HAT (hypoxantine, aminopterin, and thymidine), the de novo pathway is interfered with, and only the salvage pathway functions. As a consequence, the Hprt-deficient ES cells die; ES hybrid cells are able to survive and grow (5,6).
To succeed in obtaining ES hybrid cells, we recommend that (1) genetic markers highly expressed in the undifferentiated state are used for isolating hybrid clones, (2) the origin of somatic cells is carefully chosen for creating undifferentiated hybrid cells, and (3) the culture condition is optimized for stably maintaining the pluripotential state of ES cells and ES hybrid cells. 
Methods

Electrofusion
Feeder Cells for ES Cells
Inactivated neo r PEFs are routinely used as feeder cells for culture of ES and hybrid cells and for selection of hybrid cell colonies with G418. Use 4 × 10 5 feeder cells/30-mm culture dish, 1 × 10 6 feeder cells/60-mm culture dish, and 2.5 × 10 6 feeder cells/100-mm culture dish. 1 . Coat 60-mm culture dishes with 0.1% gelatin for at least 30 min at 37°C. 2. Incubate neo r PEFs with 10 μg/mL MMC for 2 h at 37°C in the CO 2 incubator. 3. Prepare the frozen stock of MMC-treated feeder cells at a cell concentration of 5 × 10 6 cells/mL for each cryotube. 4. Store in liquid nitrogen.
PEFs for Fused Cells
1. One day before cell fusion, coat 30-mm culture wells (6-well culture plate) with 0.1% gelatin for at least 30 min at 37°C. 2. Prepare inactivated PEFs (4 × 10 5 cells/30-mm well) in 3 mL ES medium.
ES Cells
One of the most important factors for cell fusion experiments is that the culture conditions be optimized for maintaining the pluripotential competence and full set of chromosomes (80 chromosomes) derived from mouse ES cells and somatic cells through numerous cell divisions (see Note 2).
Prepare exponentially growing ES cells cultured on the inactivated PEFs with changes of
culture medium once or twice a day. 2. Ascertain that complete sets of chromosomes are maintained in the ES cells before cell fusion.
Somatic Cells
1. Sterilize all dissection instruments (scissors and forceps) by immersion in 70% ethanol, followed by flaming. 2. Sacrifice a 6-to 8-wk-old adult mouse humanely and dissect out the thymus in a clean room if a clean bench is not available. 3. Wash the tissues with sterilized PBS twice in 60-mm Petri dishes. 4. Place the half lobe of thymus in the barrel of a sterile 2.5-mL syringe with a sterile 18-gage needle. 5. Expel and draw up the thymus gently through the needle via the tip of the needle several times in a 50-mL conical tube with 2 mL DMEM to dissociate the thymus into a single-cell suspension. 6. Keep for several min at room temperature. 7. Transfer the supernatant excluding cell clumps to a 15-mL conical tube and add 10 mL DMEM. 8. Spin down the thymocytes in 15-mL conical tubes at 300g for 5 min. 9. Resuspend the thymocytes in 10 mL DMEM. 
Purification of ES Cells
Setup of Electro Cell
Automatic Operating Parameters
Set the optimized electrical parameters to fuse ES cells and thymocytes (see Fig. 2A,B ). 
Operation of ECM 2001 With Microslides
The automatic operation switch is used to initiate AC followed by DC. AC is utilized to induce a nonhomogeneous electric field, resulting in cell alignment and pearl chain formation (see Fig. 2E ,F) (see Note 5). DC is utilized to produce reversible temporary pores in the cytoplasmic membranes. When juxtaposed pores in the physically associated cells reseal, cells have a chance to be hybridized by cytoplasmic membrane fusion. AC application after the DC pulse induces the compression of cells, which helps the process of fusion between the cell membranes. 1 . Press the automatic operation switch of the ECM 2001. 2. Add 40 μL DMEM to the fusion mixture between electrodes to induce recovery of the membrane reformation immediately after electroporation. 3. Leave the cell mixture for 10 min at room temperature. 4. Transfer the cell mixture directly to a 30-mm culture dish containing inactivated PEFs with 3 mL ES medium with LIF. 5. Repeat the cell fusion procedure sequentially using several Microslides. Usually, the cell suspension recovered from three Microslides (80 μL × 3) is plated into one 30-mm culture dish. As a control, plate the untreated cell mixture and culture it under the same conditions. 6. Incubate the cells at 37°C in the CO 2 incubator for 24 h. 7. Change the medium to ES medium with the proper supplement to select ES hybrid cells 24 h after cell fusion. 8. Change the selection medium once a day.
As a result of the 7-d treatment, nonfused ES cells and hybrid cells derived from ES cells are killed, and thymocytes are nonadherent. Thus, the hybrid cells of ES cells and somatic cells survive and form colonies. Several colonies of hybrid cells per 10 4 host ES cells appear using the previously mentioned procedures for electrofusion.
Isolation and Cloning of Hybrid Cells
Selection With G418
